During the past few years Sergei Shushunov have devoted quite a bit of time to developing new Targeted Temperature Management System for controlling body temperature in ICU settings, including use for induction of therapeutic hypothermia.
Therapeutic hypothermia, is relatively new, cost-effective treatment method for prevention or reduction of brain injury following cardiac arrest, stroke, a hypoxic event or and perhaps traumatic head injury by using total body cooling during the period of recovery from insult. The market of therapeutic hypothermia was rapidly expanding with the introduction of hypothermia induction systems based on different physiological principles until 2014, when following publication of a large study which demonstrated that hypothermia, when induced with currently available equipment does not improve outcomes. Sergei thinks the problem is due to serious drawbacks of all commercially available equipment which essentially makes it ineffective.
The ideal hypothermia machine should provide fast rate of cooling, be non-invasive, have a low side effect profile, be compact, transportable, easy to use, allow unrestricted access to the patient and allow controlled rewarming. None of the commercially available devices meet all of these criteria. Current hypothermia devices are lack uniformity, they are either too complicated to use, or don’t cool fast, or restrict access to the patients and almost all of them lack portability.
Conversely, a simple, compact, and easy to use hypothermia induction device with a favorable side effect profile can become a standard in providing hypothermia therapy. In collaboration with the Department of Engineering at the University of Kansas, Sergei have designed and built a prototype device based on a new physiological method of body cooling by administering hyper-cold air through a mechanical or manual ventilator.
New method of induction of hypothermia will address the shortcomings of the existing types of hypothermia devices and potentially replace other methods and equipment currently in use. New device would bring uniformity to the hypothermia equipment industry and expand the use of hypothermia equipment to pre-hospital settings, such as ambulances and medevac helicopters as well as to military field hospitals – the ideal settings for initiating hypothermia treatment.
Sergei applied for a patent in 2013 and is looking for investor for his company TTM Inc.
Visit this site for more information: http://hypothermiatherapy.com/